CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Clinical trial NCT01218867 · TERMINATED
Trial details
- NCT number
- NCT01218867
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-10
- Primary completion
- 2014-09-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.